tiprankstipranks
Wuxi Biologics (Cayman) Inc. (MX:2269N)
:2269N
2269N
Wuxi Biologics (Cayman)
RESEARCH TOOLSreports

Wuxi Biologics (Cayman) (2269N) Revenue

0 Followers
StatisticsMarket CapRevenue

Wuxi Biologics (Cayman) Revenue

Wuxi Biologics (Cayman) had a revenue of 11.79B in the quarter ending Jun 30, 2026, with -0.42%. This bring the company's revenue in the last twelve months to 23.62B, Decreased 8.42%. In the fiscal year ending Dec 31, 2025, Wuxi Biologics (Cayman) had annual revenue of 21.79B with 16.68% growth.
Revenue (ttm)
23.62B
Revenue Growth
10.66%
P/S Ratio
20.21
Revenue/Employee
$1,481,810
Employees
14,705
Market Cap
$440.30B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
21.79B3.11B+16.68%
Dec 31, 2024
18.68B1.64B+9.63%
Dec 31, 2023
17.03B1.77B+11.56%
Dec 31, 2022
15.27B4.98B+48.38%
Dec 31, 2021
10.29B4.68B+83.35%
Dec 31, 2020
5.61B1.63B+40.88%
Dec 31, 2019
3.98B1.45B+57.18%
Dec 31, 2018
2.53B915.62M+56.56%
Dec 31, 2017
1.62B――